Pacer Advisors Inc. Buys 687 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Pacer Advisors Inc. increased its stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 17.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,569 shares of the medical instruments supplier's stock after purchasing an additional 687 shares during the period. Pacer Advisors Inc.'s holdings in Mettler-Toledo International were worth $5,591,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in MTD. Blue Trust Inc. lifted its holdings in shares of Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier's stock valued at $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in Mettler-Toledo International during the 3rd quarter worth approximately $37,000. Raleigh Capital Management Inc. grew its stake in shares of Mettler-Toledo International by 272.7% during the 3rd quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier's stock worth $61,000 after acquiring an additional 30 shares in the last quarter. Sound Income Strategies LLC raised its holdings in shares of Mettler-Toledo International by 4,500.0% in the fourth quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier's stock valued at $56,000 after purchasing an additional 45 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. lifted its position in shares of Mettler-Toledo International by 60.0% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 18 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Insider Buying and Selling at Mettler-Toledo International

In other news, insider Gerry Keller sold 140 shares of the firm's stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the transaction, the insider now directly owns 6 shares of the company's stock, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of the business's stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares of the company's stock, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock traded up $27.21 during mid-day trading on Thursday, hitting $1,362.71. 121,145 shares of the company's stock traded hands, compared to its average volume of 115,808. The stock has a market cap of $28.75 billion, a price-to-earnings ratio of 36.74, a P/E/G ratio of 4.19 and a beta of 1.12. The firm has a 50 day simple moving average of $1,260.70 and a two-hundred day simple moving average of $1,343.47. Mettler-Toledo International Inc. has a fifty-two week low of $1,133.46 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The firm had revenue of $954.54 million for the quarter, compared to analysts' expectations of $941.93 million. On average, research analysts anticipate that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on MTD shares. Citigroup upgraded shares of Mettler-Toledo International from a "sell" rating to a "neutral" rating and lifted their price target for the company from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Stifel Nicolaus lowered their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a research report on Monday, November 11th. Robert W. Baird reduced their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a research report on Monday, November 11th. Evercore ISI raised Mettler-Toledo International from an "in-line" rating to an "outperform" rating and boosted their price target for the stock from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Finally, Wolfe Research initiated coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a "peer perform" rating for the company. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Mettler-Toledo International presently has an average rating of "Hold" and a consensus target price of $1,351.25.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.